HSBC Holdings’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $543K | Sell |
66,882
-19,830
| -23% | -$161K | ﹤0.01% | 1673 |
|
2025
Q1 | $727K | Buy |
86,712
+26,651
| +44% | +$223K | ﹤0.01% | 1482 |
|
2024
Q4 | $476K | Buy |
60,061
+13,757
| +30% | +$109K | ﹤0.01% | 1814 |
|
2024
Q3 | $381K | Buy |
46,304
+2,463
| +6% | +$20.3K | ﹤0.01% | 1805 |
|
2024
Q2 | $279K | Sell |
43,841
-247,568
| -85% | -$1.57M | ﹤0.01% | 1985 |
|
2024
Q1 | $1.76M | Buy |
+291,409
| New | +$1.76M | ﹤0.01% | 1233 |
|
2023
Q4 | – | Sell |
-11,433
| Closed | -$47.9K | – | 2224 |
|
2023
Q3 | $47.9K | Buy |
+11,433
| New | +$47.9K | ﹤0.01% | 2117 |
|
2023
Q2 | – | Sell |
-41,979
| Closed | -$58.9K | – | 2102 |
|
2023
Q1 | $58.9K | Hold |
41,979
| – | – | ﹤0.01% | 2118 |
|
2022
Q4 | $83.1K | Buy |
41,979
+2,536
| +6% | +$5.02K | ﹤0.01% | 2443 |
|
2022
Q3 | $82K | Sell |
39,443
-26,460
| -40% | -$55K | ﹤0.01% | 2320 |
|
2022
Q2 | $214K | Buy |
65,903
+9,735
| +17% | +$31.6K | ﹤0.01% | 2425 |
|
2022
Q1 | $236K | Buy |
56,168
+61
| +0.1% | +$256 | ﹤0.01% | 2531 |
|
2021
Q4 | $272K | Buy |
+56,107
| New | +$272K | ﹤0.01% | 2368 |
|
2020
Q3 | – | Sell |
-18,751
| Closed | -$89K | – | 2250 |
|
2020
Q2 | $89K | Sell |
18,751
-1,798
| -9% | -$8.53K | ﹤0.01% | 2146 |
|
2020
Q1 | $69K | Sell |
20,549
-52,431
| -72% | -$176K | ﹤0.01% | 2097 |
|
2019
Q4 | $351K | Sell |
72,980
-47,794
| -40% | -$230K | ﹤0.01% | 1914 |
|
2019
Q3 | $350K | Buy |
+120,774
| New | +$350K | ﹤0.01% | 1959 |
|
2019
Q2 | – | Sell |
-31,356
| Closed | -$445K | – | 2095 |
|
2019
Q1 | $445K | Buy |
31,356
+5,419
| +21% | +$76.9K | ﹤0.01% | 1652 |
|
2018
Q4 | $350K | Sell |
25,937
-2,676
| -9% | -$36.1K | ﹤0.01% | 1640 |
|
2018
Q3 | $635K | Buy |
28,613
+3,706
| +15% | +$82.2K | ﹤0.01% | 1399 |
|
2018
Q2 | $409K | Buy |
+24,907
| New | +$409K | ﹤0.01% | 1615 |
|